Meningioma epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(34 intermediate revisions by 3 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Meningioma}}
{{Meningioma}}
{{CMG}} {{AE}}{{HL}}
{{CMG}} {{AE}} {{IO}} {{HL}}


==Overview==
==Overview==
The incidence of meningioma is approximately 12 per 100,000 individuals in the united states.<ref name="pmid20821343">{{cite journal| author=Wiemels J, Wrensch M, Claus EB| title=Epidemiology and etiology of meningioma. | journal=J Neurooncol | year= 2010 | volume= 99 | issue= 3 | pages= 307-14 | pmid=20821343 | doi=10.1007/s11060-010-0386-3 | pmc=PMC2945461 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20821343  }} </ref> The prevalence of meningioma was estimated to be 97.5 cases per 100,000 individuals in the United States.<ref name="pmid20821343">{{cite journal| author=Wiemels J, Wrensch M, Claus EB| title=Epidemiology and etiology of meningioma. | journal=J Neurooncol | year= 2010 | volume= 99 | issue= 3 | pages= 307-14 | pmid=20821343 | doi=10.1007/s11060-010-0386-3 | pmc=PMC2945461 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20821343  }} </ref> Meningiomas may appear at any age, but are most commonly noticed among patients older than 50 years of age.<ref name="wiki">Meningioma. Wikipedia(2015) https://en.wikipedia.org/wiki/Meningioma#cite_note-pmid7731706-9 Accessed on September, 25th 2015</ref> Females are more commonly affected with meningiomas than males.<ref name="pmid20821343">{{cite journal| author=Wiemels J, Wrensch M, Claus EB| title=Epidemiology and etiology of meningioma. | journal=J Neurooncol | year= 2010 | volume= 99 | issue= 3 | pages= 307-14 | pmid=20821343 | doi=10.1007/s11060-010-0386-3 | pmc=PMC2945461 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20821343  }} </ref> Meningioma usually affects individuals of the african american race. Caucasian and latin american individuals are less likely to develop meningioma.<ref name="pmid20821343">{{cite journal| author=Wiemels J, Wrensch M, Claus EB| title=Epidemiology and etiology of meningioma. | journal=J Neurooncol | year= 2010 | volume= 99 | issue= 3 | pages= 307-14 | pmid=20821343 | doi=10.1007/s11060-010-0386-3 | pmc=PMC2945461 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20821343  }} </ref>
The prevalence of meningioma is estimated to be 97.5 cases per 100,000 individuals in the United States. The incidence of meningioma is approximately 7.62 per 100,000 individuals in the United States. Meningiomas may appear at any age, but are most commonly noticed among patients older than 50 years of age. Females are more commonly affected with meningiomas than males, with a ratio of about 2:1. Meningioma usually affects individuals of the African American race. Caucasian and Latin American individuals are less likely to develop meningioma.


==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Incidence===
* The advent of modern sophisticated imaging studies tripled the incidence of asymptomatic meningiomas.<ref name="wiki">Meningioma. Wikipedia(2015) https://en.wikipedia.org/wiki/Meningioma#cite_note-pmid7731706-9 Accessed on September, 25th 2015</ref>


===Prevalence===
===Prevalence===
* The prevalence of meningioma was estimated to be 97.5 cases per 100,000 individuals in the United States.<ref name="pmid20821343">{{cite journal| author=Wiemels J, Wrensch M, Claus EB| title=Epidemiology and etiology of meningioma. | journal=J Neurooncol | year= 2010 | volume= 99 | issue= 3 | pages= 307-14 | pmid=20821343 | doi=10.1007/s11060-010-0386-3 | pmc=PMC2945461 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20821343  }} </ref>
* The prevalence of meningioma is estimated to be 97.5 cases per 100,000 individuals in the United States. There are over 170,000 diagnosed cases in the United States.<ref name="pmid20821343">{{cite journal| author=Wiemels J, Wrensch M, Claus EB| title=Epidemiology and etiology of meningioma. | journal=J Neurooncol | year= 2010 | volume= 99 | issue= 3 | pages= 307-14 | pmid=20821343 | doi=10.1007/s11060-010-0386-3 | pmc=PMC2945461 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20821343  }} </ref>
* It was the most reported primary [[brain]] and [[central nervous system]] [[tumor]] in the Unites States between 2002 and 2006. It accounted for about 33.8% of the tumors reported, making it the most frequently diagnosed [[brain tumor]].<ref name="pmid20821343">{{cite journal| author=Wiemels J, Wrensch M, Claus EB| title=Epidemiology and etiology of meningioma. | journal=J Neurooncol | year= 2010 | volume= 99 | issue= 3 | pages= 307-14 | pmid=20821343 | doi=10.1007/s11060-010-0386-3 | pmc=2945461 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20821343  }} </ref>  
* Meningioma is the second most common primary [[brain tumor]] worldwide.<ref name="pmid21955199">{{cite journal| author=Chamberlain MC, Barnholtz-Sloan JS| title=Medical treatment of recurrent meningiomas. | journal=Expert Rev Neurother | year= 2011 | volume= 11 | issue= 10 | pages= 1425-32 | pmid=21955199 | doi=10.1586/ern.11.38 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21955199  }} </ref>
* Meningioma is the second most common primary [[brain tumor]] worldwide.<ref name="pmid21955199">{{cite journal| author=Chamberlain MC, Barnholtz-Sloan JS| title=Medical treatment of recurrent meningiomas. | journal=Expert Rev Neurother | year= 2011 | volume= 11 | issue= 10 | pages= 1425-32 | pmid=21955199 | doi=10.1586/ern.11.38 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21955199  }} </ref>
* Meningioma accounts for approximately 1 out of 3 primary [[brain]] and [[spinal cord]] [[tumor]]s.<ref name="C">Meningioma. Canadian Cancer Society http://www.cancer.ca/en/cancer-information/cancer-type/brain-spinal/brain-and-spinal-tumours/meningioma/?region=mb September, 25th 2015</ref>
 
* The prevalence of meningioma was estimated to be around 170,000 individuals in the United States.<ref name="pmid20821343">{{cite journal| author=Wiemels J, Wrensch M, Claus EB| title=Epidemiology and etiology of meningioma. | journal=J Neurooncol | year= 2010 | volume= 99 | issue= 3 | pages= 307-14 | pmid=20821343 | doi=10.1007/s11060-010-0386-3 | pmc=PMC2945461 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20821343 }} </ref>
===Incidence===
* [[Benign]] meningiomas account for approximately 70% of all meningioma cases.<ref name="C">Meningioma. Canadian Cancer Society http://www.cancer.ca/en/cancer-information/cancer-type/brain-spinal/brain-and-spinal-tumours/meningioma/?region=mb September, 25th 2015</ref>
* The incidence of meningiomas annually is approximately 7.62 per 100,000 individuals in the United States. The incidence of [[benign]] meningiomas is about 7.18, about 0.32 for borderline [[malignant]] meningiomas, and about 0.12 for [[malignant]] meningiomas.<ref name="pmid25872752">{{cite journal| author=Dolecek TA, Dressler EV, Thakkar JP, Liu M, Al-Qaisi A, Villano JL| title=Epidemiology of meningiomas post-Public Law 107-206: The Benign Brain Tumor Cancer Registries Amendment Act. | journal=Cancer | year= 2015 | volume= 121 | issue= 14 | pages= 2400-10 | pmid=25872752 | doi=10.1002/cncr.29379 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25872752 }} </ref>
* Atypical meningiomas account for approximately 15%–25% of all meningioma cases.<ref name="C">Meningioma. Canadian Cancer Society http://www.cancer.ca/en/cancer-information/cancer-type/brain-spinal/brain-and-spinal-tumours/meningioma/?region=mb September, 25th 2015</ref>
* [[Anaplastic]] or [[malignant]] meningiomas account for about 1%–3% of all meningioma cases.<ref name="C">Meningioma. Canadian Cancer Society http://www.cancer.ca/en/cancer-information/cancer-type/brain-spinal/brain-and-spinal-tumours/meningioma/?region=mb September, 25th 2015</ref>


===Age===
===Age===
* Meningiomas may appear at any age, but are most commonly noticed among patients older than 50 years of age.<ref name="wiki">Meningioma. Wikipedia(2015) https://en.wikipedia.org/wiki/Meningioma#cite_note-pmid7731706-9 Accessed on September, 25th 2015</ref>  
* Meningiomas can occur at any age but is mostly seen with advancing age. <ref name="pmid25872752">{{cite journal| author=Dolecek TA, Dressler EV, Thakkar JP, Liu M, Al-Qaisi A, Villano JL| title=Epidemiology of meningiomas post-Public Law 107-206: The Benign Brain Tumor Cancer Registries Amendment Act. | journal=Cancer | year= 2015 | volume= 121 | issue= 14 | pages= 2400-10 | pmid=25872752 | doi=10.1002/cncr.29379 | pmc=5549267 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25872752  }} </ref>
* Meningiomas are uncommon among patients before the age of 40 and should raise suspicion of [[neurofibromatosis type 2]] (NF2) when found among young patients.<ref name="radio">Meningeoma. Radiopaedia(2015)http://radiopaedia.org/articles/meningioma Accessed on September, 25th 2015</ref>
* It is commonly seen between the ages of 40 to 60 and is more common in [[postmenopausal]] women.<ref name="pmid29492130">{{cite journal| author=Gurcay AG, Bozkurt I, Senturk S, Kazanci A, Gurcan O, Turkoglu OF et al.| title=Diagnosis, Treatment, and Management Strategy of Meningioma during Pregnancy. | journal=Asian J Neurosurg | year= 2018 | volume= 13 | issue= 1 | pages= 86-89 | pmid=29492130 | doi=10.4103/1793-5482.181115 | pmc=5820904 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=29492130  }} </ref>
* In childhood and adolescence, meningiomas account for about 1.5% of [[Brain tumor|brain tumors]].<ref name="pmid30740161">{{cite journal| author=Sumkovski R, Micunovic M, Kocevski I, Ilievski B, Petrov I| title=Surgical Treatment of Meningiomas - Outcome Associated With Type of Resection, Recurrence, Karnofsky Performance Score, Mitotic Count. | journal=Open Access Maced J Med Sci | year= 2019 | volume= 7 | issue= 1 | pages= 56-64 | pmid=30740161 | doi=10.3889/oamjms.2018.503 | pmc=6352459 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30740161  }} </ref>


===Gender===
===Gender===
* Females are more commonly affected with meningiomas than males.<ref name="pmid20821343">{{cite journal| author=Wiemels J, Wrensch M, Claus EB| title=Epidemiology and etiology of meningioma. | journal=J Neurooncol | year= 2010 | volume= 99 | issue= 3 | pages= 307-14 | pmid=20821343 | doi=10.1007/s11060-010-0386-3 | pmc=PMC2945461 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20821343  }} </ref>
* Females are more commonly affected with meningiomas than males.<ref name="pmid20821343">{{cite journal| author=Wiemels J, Wrensch M, Claus EB| title=Epidemiology and etiology of meningioma. | journal=J Neurooncol | year= 2010 | volume= 99 | issue= 3 | pages= 307-14 | pmid=20821343 | doi=10.1007/s11060-010-0386-3 | pmc=PMC2945461 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20821343  }} </ref>
* The female to male ratio is approximately 2 to 1.<ref name="pmid20821343">{{cite journal| author=Wiemels J, Wrensch M, Claus EB| title=Epidemiology and etiology of meningioma. | journal=J Neurooncol | year= 2010 | volume= 99 | issue= 3 | pages= 307-14 | pmid=20821343 | doi=10.1007/s11060-010-0386-3 | pmc=PMC2945461 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20821343 }} </ref>
* The female to male ratio is approximately 2 to 1.
* The incidence of meningioma among females is approximately 8.36 per 100,000 individuals in the united states<ref name="pmid20821343">{{cite journal| author=Wiemels J, Wrensch M, Claus EB| title=Epidemiology and etiology of meningioma. | journal=J Neurooncol | year= 2010 | volume= 99 | issue= 3 | pages= 307-14 | pmid=20821343 | doi=10.1007/s11060-010-0386-3 | pmc=PMC2945461 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20821343 }} </ref>.
* The incidence of meningioma among females is approximately 8.36 per 100,000 individuals in the United States, with that of males being 3.61 per 100,000 individuals.<ref name="pmid20821343">Wiemels J, Wrensch M, Claus EB (2010) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=20821343 Epidemiology and etiology of meningioma.] ''J Neurooncol'' 99 (3):307-14. [http://dx.doi.org/10.1007/s11060-010-0386-3 DOI:10.1007/s11060-010-0386-3] PMID: [https://pubmed.gov/20821343 20821343]</ref>
* The incidence of meningioma among males is approximately 3.61 per 100,000 individuals in the united states.<ref name="pmid20821343">{{cite journal| author=Wiemels J, Wrensch M, Claus EB| title=Epidemiology and etiology of meningioma. | journal=J Neurooncol | year= 2010 | volume= 99 | issue= 3 | pages= 307-14 | pmid=20821343 | doi=10.1007/s11060-010-0386-3 | pmc=PMC2945461 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20821343  }} </ref>
* The female to male ratio of meningiomas may be inverted among affected patients who are younger than 15 years of age.<ref name="pmid20821343">{{cite journal| author=Wiemels J, Wrensch M, Claus EB| title=Epidemiology and etiology of meningioma. | journal=J Neurooncol | year= 2010 | volume= 99 | issue= 3 | pages= 307-14 | pmid=20821343 | doi=10.1007/s11060-010-0386-3 | pmc=PMC2945461 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20821343  }} </ref>
* The female to male ratio of meningiomas may be inverted among patients who are younger than 15 years of age.<ref name="pmid20821343">{{cite journal| author=Wiemels J, Wrensch M, Claus EB| title=Epidemiology and etiology of meningioma. | journal=J Neurooncol | year= 2010 | volume= 99 | issue= 3 | pages= 307-14 | pmid=20821343 | doi=10.1007/s11060-010-0386-3 | pmc=PMC2945461 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20821343 }} </ref>
* Atypical and malignant meningiomas have a slight male predominace.<ref name="pmid20821343">Wiemels J, Wrensch M, Claus EB (2010) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=20821343 Epidemiology and etiology of meningioma.] ''J Neurooncol'' 99 (3):307-14. [http://dx.doi.org/10.1007/s11060-010-0386-3 DOI:10.1007/s11060-010-0386-3] PMID: [https://pubmed.gov/20821343 20821343]</ref>


===Race===
===Race===
* Meningioma usually affects individuals of the african american race. Caucasian and latin american individuals are less likely to develop meningioma.<ref name="pmid20821343">{{cite journal| author=Wiemels J, Wrensch M, Claus EB| title=Epidemiology and etiology of meningioma. | journal=J Neurooncol | year= 2010 | volume= 99 | issue= 3 | pages= 307-14 | pmid=20821343 | doi=10.1007/s11060-010-0386-3 | pmc=PMC2945461 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20821343  }} </ref>
* Meningioma usually affects individuals of the black race. Caucasian and Latin American individuals are less likely to develop meningioma.<ref name="pmid20821343">{{cite journal| author=Wiemels J, Wrensch M, Claus EB| title=Epidemiology and etiology of meningioma. | journal=J Neurooncol | year= 2010 | volume= 99 | issue= 3 | pages= 307-14 | pmid=20821343 | doi=10.1007/s11060-010-0386-3 | pmc=PMC2945461 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20821343  }} </ref>


==References==
==References==


{{Reflist|2}}
{{Reflist|2}}


[[Category:Disease]]
[[Category:Disease]]
Line 44: Line 40:
[[Category:Neurosurgery]]
[[Category:Neurosurgery]]
[[Category:Neurology]]
[[Category:Neurology]]
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Neurology]]
[[Category:Neurosurgery]]

Latest revision as of 14:31, 10 September 2019

Meningioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Meningioma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Meningioma epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Meningioma epidemiology and demographics

All Images
X-rays
Echo and Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Meningioma epidemiology and demographics

CDC on Meningioma epidemiology and demographics

Meningioma epidemiology and demographics in the news

Blogs on Meningioma epidemiology and demographics

Directions to Hospitals Treating Meningioma

Risk calculators and risk factors for Meningioma epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ifeoma Odukwe, M.D. [2] Haytham Allaham, M.D. [3]

Overview

The prevalence of meningioma is estimated to be 97.5 cases per 100,000 individuals in the United States. The incidence of meningioma is approximately 7.62 per 100,000 individuals in the United States. Meningiomas may appear at any age, but are most commonly noticed among patients older than 50 years of age. Females are more commonly affected with meningiomas than males, with a ratio of about 2:1. Meningioma usually affects individuals of the African American race. Caucasian and Latin American individuals are less likely to develop meningioma.

Epidemiology and Demographics

Prevalence

  • The prevalence of meningioma is estimated to be 97.5 cases per 100,000 individuals in the United States. There are over 170,000 diagnosed cases in the United States.[1]
  • It was the most reported primary brain and central nervous system tumor in the Unites States between 2002 and 2006. It accounted for about 33.8% of the tumors reported, making it the most frequently diagnosed brain tumor.[1]
  • Meningioma is the second most common primary brain tumor worldwide.[2]

Incidence

  • The incidence of meningiomas annually is approximately 7.62 per 100,000 individuals in the United States. The incidence of benign meningiomas is about 7.18, about 0.32 for borderline malignant meningiomas, and about 0.12 for malignant meningiomas.[3]

Age

  • Meningiomas can occur at any age but is mostly seen with advancing age. [3]
  • It is commonly seen between the ages of 40 to 60 and is more common in postmenopausal women.[4]
  • In childhood and adolescence, meningiomas account for about 1.5% of brain tumors.[5]

Gender

  • Females are more commonly affected with meningiomas than males.[1]
  • The female to male ratio is approximately 2 to 1.
  • The incidence of meningioma among females is approximately 8.36 per 100,000 individuals in the United States, with that of males being 3.61 per 100,000 individuals.[1]
  • The female to male ratio of meningiomas may be inverted among affected patients who are younger than 15 years of age.[1]
  • Atypical and malignant meningiomas have a slight male predominace.[1]

Race

  • Meningioma usually affects individuals of the black race. Caucasian and Latin American individuals are less likely to develop meningioma.[1]

References

  1. 1.0 1.1 1.2 1.3 1.4 1.5 1.6 Wiemels J, Wrensch M, Claus EB (2010). "Epidemiology and etiology of meningioma". J Neurooncol. 99 (3): 307–14. doi:10.1007/s11060-010-0386-3. PMC 2945461. PMID 20821343.
  2. Chamberlain MC, Barnholtz-Sloan JS (2011). "Medical treatment of recurrent meningiomas". Expert Rev Neurother. 11 (10): 1425–32. doi:10.1586/ern.11.38. PMID 21955199.
  3. 3.0 3.1 Dolecek TA, Dressler EV, Thakkar JP, Liu M, Al-Qaisi A, Villano JL (2015). "Epidemiology of meningiomas post-Public Law 107-206: The Benign Brain Tumor Cancer Registries Amendment Act". Cancer. 121 (14): 2400–10. doi:10.1002/cncr.29379. PMID 25872752.
  4. Gurcay AG, Bozkurt I, Senturk S, Kazanci A, Gurcan O, Turkoglu OF; et al. (2018). "Diagnosis, Treatment, and Management Strategy of Meningioma during Pregnancy". Asian J Neurosurg. 13 (1): 86–89. doi:10.4103/1793-5482.181115. PMC 5820904. PMID 29492130.
  5. Sumkovski R, Micunovic M, Kocevski I, Ilievski B, Petrov I (2019). "Surgical Treatment of Meningiomas - Outcome Associated With Type of Resection, Recurrence, Karnofsky Performance Score, Mitotic Count". Open Access Maced J Med Sci. 7 (1): 56–64. doi:10.3889/oamjms.2018.503. PMC 6352459. PMID 30740161.